ArticleFrontiers in cardiovascular medicine2026
Interpretable gradient boosting machine model for predicting in-hospital mortality in sepsis-induced myocardial injury: a multicenter development, validation, and web-based clinical implementation.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sepsis-induced myocardial injury (SIMI) is a life-threatening complication of sepsis, associated with high in-hospital mortality. Current risk prediction models for SIMI lack interpretability and multi-center validation, necessitating advanced analytical approaches to improve risk stratification and clinical decision-making. Method: In this study, LASSO regression for feature selection, eight machine learning algorithms were evaluated, including Gradient Boosting Machine (GBM), XGBoost, and Logistic Regression. Model performance was assessed via AUC, sensitivity, specificity, and calibration curves. SHapley Additive exPlanations (SHAP) were used to interpret feature contributions, and recursive feature elimination optimized the model for clinical usability. Result: The GBM model demonstrated optimal performance with an internal validation AUC of 0.751 (95% CI: 0.614-0.867), outperforming other algorithms (e.g., SVM: 0.733, LR: 0.730). External validation in eICU and the Chinese cohort yielded AUCs of 0.924 and 0.703, respectively, confirming generalizability. Key predictors identified by SHAP included APS III Score, Hypertension, Albumin, Diabetes, SOFA Score, ALT, RBC, and Lactate. A simplified model with five variables (age, SOFA score, APS III score, albumin, ALT) achieved an AUC of 0.789 and was deployed on a user-friendly platform (https://anyuanning.shinyapps.io/SIMI/), enabling real-time risk assessment for clinicians. Conclusion: This multicenter study developed an interpretable predictive model to predict in-hospital mortality in patients with sepsis-induced myocardial injury (SIMI) and deployed it on a user-friendly platform, potentially improving patient outcomes through early risk assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.